Biostar Pharmaceuticals, Inc. Files SEC Form SC 13D, General Statement of Acquisition of Beneficial Ownership: (Jul. 2, 2018)

Pharma Business Week |

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Biostar Pharmaceuticals, Inc. (Form SC 13D) was posted on .

The SIC code for this company is 2834, Pharmaceutical Preparations.

The SEC file number is 0001185185-18-001206.

The contact information for this company is NO. 588 SHIJI XI AVENUE, XIANYANG, SHAANXI PROVINCE F4 712046, 011-86-29-33686638.

Our editors provided additional information about Form SC 13D: This Schedule discloses beneficial ownership of certain registered equity securities. Any person or group of persons who acquire a beneficial ownership of more than 5% of a class of registered equity securities of certain issuers must file a Schedule 13D reporting such acquisition together with certain other information within ten days after such acquisition. Moreover, any material changes in the facts set forth in the Schedule generally precipitates a duty to promptly file an amendment on Schedule 13D. The Commission's rules define the term "beneficial owner" to be any person who directly or indirectly shares voting power or investment power (the power to sell the security).

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1418133/0001185185-18-001206-index.html.

Keywords for this news article include: Biostar Pharmaceuticals Inc., Pharmaceutical Companies, Pharmaceutical Preparations, Business, SEC Filing.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…